NOTA Laboratories, Inc.

NOTA Laboratories is a biomedical R&D company focused on the therapeutic applications of inhaled nitric oxide (iNO). The company develops novel nitric oxide-based treatments leveraging NO's broad biological roles as an immune modulator, potent vasodilator, and antimicrobial agent. Its pipeline targets pulmonary hypertension, chronic airway infections (CF, COPD, sinusitis, tuberculosis), primary graft failure prevention in lung transplantation, antiviral therapy, and thrombosis prevention during extracorporeal circulation. NOTA Laboratories has received multiple SBIR/STTR grants from the NIH and holds partnerships with the University of Michigan.